Benicar HCT (Olmesartan Medoxomil / Hydrochlorothiazide) - Summary

BENICAR HCT SUMMARY

BENICAR HCT™ (olmesartan medoxomil-hydrochlorothiazide) is a combination of an angiotensin II receptor antagonist (AT₁ subtype), olmesartan medoxomil, and a thiazide diuretic, hydrochlorothiazide (HCTZ).

BENICAR HCT™ is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial therapy (see DOSAGE AND ADMINISTRATION).

BENICAR HCT NEWS HIGHLIGHTS

Media Articles Related to Benicar HCT (Olmesartan / Hydrochlorothiazide)

Treatment Of Lung Hypertension Does Not Help Patients With Chronic Bronchitis
Source: Respiratory / Asthma News From Medical News Today [2008.08.29]

Possible Association Between High Levels Of Uric Acid And Hypertension
Source: Hypertension News From Medical News Today [2008.08.28]

Allopurinol May Lower Blood Pressure In Teens With Hypertension
Source: Hypertension News From Medical News Today [2008.08.28]

Drug Designed To Lower Uric Acid Levels May Be Useful For Hypertension
Source: Blood / Hematology News From Medical News Today [2008.08.27]

Reducing Uric Acid Shows Promise for Hypertension in Children
Source: MedPage Today Nephrology [2008.08.26]

more>>

Published Studies Related to Benicar HCT (Olmesartan / Hydrochlorothiazide)

Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients. [2008]

Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide. [2004.03]

A review of olmesartan medoxomil monotherapy: antihypertensive efficacy similar to that of other angiotensin II receptor blocker/hydrochlorothiazide combinations? [2002.11]

Effects of Manidipine/Delapril versus Olmesartan/Hydrochlorothiazide Combination Therapy in Elderly Hypertensive Patients with Type 2 Diabetes Mellitus. [2008.01]

Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension. [2005.11]

more>>

Clinical Trials Related to Benicar HCT (Olmesartan / Hydrochlorothiazide)

Olmesartan in Essential Hypertension [Completed]

An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension [Completed]

Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg [Completed]

Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg [Completed]

Olmesartan and an Add-on Treatment in Patients With Mild to Moderate Hypertension [Completed]

more>>